AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth 
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds 
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours 
Middle East Conflict Impacts Australia and New Zealand Businesses 
Agentic AI Boom to Drive Massive Growth in CPU Market, UBS Says 
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy 
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations 
EDEN PRAIRIE, Minn., May 01, 2018 -- CHF Solutions, Inc. (Nasdaq:CHFS) announces today that its first quarter financial results will be released on Tuesday, May 8, 2018. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
To access the live webcast, please visit the CHF Solutions website at http://ir.chf-solutions.com or access the webcast directly at https://edge.media-server.com/m6/p/dxgvnn8x. Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID 8694787. An audio archive of the webcast and the call script will be available following the call on the Investor page at www.chf-solutions.com.
About CHF Solutions
CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's mission is to predict, measure, and control patient fluid balance through science, collaboration, and innovative medical technology. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.
CONTACTS:
INVESTORS:
Claudia Napal Drayton
Chief Financial Officer
CHF Solutions, Inc.
952-345-4205
[email protected]
-or-
Bret Shapiro
Managing Partner
CORE IR
516-222-2560
[email protected]
www.coreir.com
MEDIA
Jules Abraham
JQA Partners, Inc.
917-885-7378
[email protected]
